Dr. Niels Pedersen’s Publications by Year

• 2024 Dr. Pedersen’s Winter Update

• 2024 FROM UC DAVIS Dr. Brian Murphy: Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials

• 2023 report on the status of SOCK FIP and FIP research at UC Davis and possible directions for future FIP research

• 2023 Neurological and Ocular FIP Update

• 2021 The Long History of Beta-d-N4-hydroxycytidine and Its Modern Application to the Treatment of Covid-19 in People and FIP In Cats

• 2021 FIP treatment with oral formulations of GS-441524

• 2021 Origin of abdominal or thoracic effusions in cats with wet FIP and reasons for their persistence during treatment

• 2021 The Neurological Form of FIP and Treatment with GS-441524

• 2021 Story About Supplements

• 2021 FELV Infection and FIP

• 2021 FIP in Pregnant Cats

• 2021 FIP in Aged Cats

• 2021 Treatment with Oral Formulations of GS 441524

• 2021 Neurological and Ocular FIP

• 2020 Summary of GS-441524 Treatment For FIP

• 2020 Dr. Pedersen New Year’s Update

• 2020 Coronavirus: Black Market Cure For Cats With Feline Infectious Peritonitis Is Illegal, But Is Saving Thousands of Lives

• 2019 Dr. Pedersen Fall Update

• 2019 Dr. Pedersen Personal Statement

• 2019 Efficacy and Safety of the Nucleoside Analog GS441524 for Treatment of Cats With Naturally Occurring Feline Infectious Peritonitis

• 2019 Dr. Pedersen New Year’s Update

• 2019 Dr. Pedersen Spring Research Update

• 2019 Legal Treatment For Cat Disease Known As FIP Still Years Away

• 2019 Hope, Despair Fuel Black Market For Drugs in Fatal Cat Disease

• 2018 Dr. Pedersen Summer Update

• 2017 Dr. Pedersen Fall Update

• 2016 Dr. Pedersen Fall Update

• 2016 Dr. Pedersen Trial Update: Anti-Viral Trial Preliminary Report

• 2015 Dr. Pedersen Summary

• 2015 Interview with Dr. Niels Pedersen Concerning an Outbreak of FIP in a Shelter

• 2014 Dr. Pedersen Fall Research Note

• 2014 Dr. Pedersen Year-End Research Update

Worldwide FIP Research  

• Fecal Feline Coronavirus RNA Shedding and Spike Gene Mutations in Cats with Feline Infectious Peritonitis Treated with GS-441524

• An updated review of feline coronavirus: mind the two biotypes

• Quality assessment and characterization of unregulated antiviral drugs for feline infectious peritonitis: implications for treatment, safety, and efficacy

• Efficacy of Oral Remdesivir Compared to GS-441524 for Treatment of Cats with Naturally Occurring Effusive Feline Infectious Peritonitis: A Blinded, Non-Inferiority Study

• Treatment of FIP in cats with Remdesivir –

• A key role for molnupiravir in the management of cats with FIP in Australia –

• Effect of GS-441524 in combination with the 3C-like protease inhibitor GC376 on the treatment of naturally transmitted feline infectious peritonitis

• Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical Signs

• An Optimized Bioassay for Screening Combined Anitcoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats

• Could Molnupiravir Have an Ameliorative Effect In Pets with COVID-19?

• An update on the treatment of FIP in the UK

• Unlicensed Molnupiravir is an Effective Rescue Treatment Following the Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis

• Magic Year of Ernie

• Ongoing statistical analysis of GS-441524 treated cats amassed by FIP Warriors in the Czech Republic and Slovakia.

• FIP Treatment Guide for Veterinary Professional

• NIH Agrees With Public Citizen, Will Conduct Preclinical Trials of the Potential COVID-19 Treatment GS-441524

• Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis.

• Inside a Facebook ‘Dallas Buyers Club’ for Cat Drugs

• Advantages of the parent nucleoside GS-441524 over remdesivir for COVID-19 treatment 

• Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis

• Feline Infectious Peritonitis (FIP). What Happened, Why It Happened. What Will Happen to My Cat and What Are My Options?

• Treatment of FIP in cats with Remdesivir – April 2021

• Treatment of FIP in cats with subcutaneous Remdesivir followed by oral GS-441524 tables 

Veterinary researchers and Anivive license antiviral drug for fatal cat disease - 9/29/2018 

The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies - 9/22/2018 

Niels Pedersen Podcast Part #1 & #2 from Winn Feline Foundation 2017 Symposium - Ending FIP, Is There Hope? Your Weekly Winn - 7/5/2017 

Ending FIP.  Is There Hope: Winn Feline Symposium - 6/5/2017 

Veterinary researchers close in on FIP treatment - 5/24/2017 

Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor - 5/30/2016 

Feline Infectious Peritonitis - January 2015 (Winn Foundation Publication) 

Prolonged survival of a cat diagnosed with feline infectious peritonitis by immunohistochemistry - 1/2015 

An update on feline infectious peritonitis: Diagnostics and therapeutics - 8/2014 

An outbreak of feline infectious peritonitis in a Taiwanese shelter: epidemiologic and molecular evidence for horizontal transmission of a novel type II feline coronavirus - 7/17/2013

Interview by Anna-Lena Berg w/ Dr. Niels Pedersen Feline Husbandry, Diseases and Management in the Multi-Cat Environment, by Dr. Niels Pedersen DVM, PhD

Dr. Pedersen’s book is out of print and near impossible to find. This link contains a PDF version of Dr. Niels Pedersen's book, which was published in 1991  www.stopFIP.org